Bank Julius Baer & Co
BSX icon

Bank Julius Baer & Co’s Boston Scientific BSX Stock Holding History

Bank Julius Baer & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$840K Sell
19,650
-185,654
-90% -$10.1M ﹤0.01% 413
2026
Q1 		$12.9M Sell
205,304
-264,018
-56% -$21.1M 0.04% 164
2025
Q4 		$44.8M Buy
469,322
+215,875
+85% +$21.2M 0.12% 118
2025
Q3 		$24.7M Sell
253,447
-7,376
-3% -$764K 0.07% 136
2025
Q2 		$28M Sell
260,823
-16,902
-6% -$1.71M 0.08% 123
2025
Q1 		$27.9M Sell
277,725
-13,701
-5% -$1.38M 0.09% 122
2024
Q4 		$27.6M Buy
291,426
+1,316
+0.5% +$116K 0.09% 130
2024
Q3 		$26.7M Sell
290,110
-11,090
-4% -$874K 0.09% 114
2024
Q2 		$24.6M Sell
301,200
-46,688
-13% -$3.42M 0.09% 109
2024
Q1 		$23.7M Buy
347,888
+15,285
+5% +$983K 0.09% 118
2023
Q4 		$19.2M Buy
332,603
+56,982
+21% +$3.04M 0.08% 139
2023
Q3 		$14.6M Sell
275,621
-14,306
-5% -$750K 0.08% 127
2023
Q2 		$15.7M Sell
289,927
-16,070
-5% -$839K 0.09% 128
2023
Q1 		$15.3M Buy
305,997
+18,007
+6% +$849K 0.1% 128
2022
Q4 		$13.3M Buy
287,990
+18,121
+7% +$785K 0.09% 132
2022
Q3 		$10.5M Sell
269,869
-3,787
-1% -$152K 0.08% 132
2022
Q2 		$10.2M Buy
273,656
+4,487
+2% +$183K 0.07% 135
2022
Q1 		$11.9M Sell
269,169
-15,010
-5% -$651K 0.07% 125
2021
Q4 		$12.1M Sell
284,179
-28,176
-9% -$1.18M 0.06% 143
2021
Q3 		$13.6M Buy
312,355
+25,545
+9% +$1.13M 0.08% 144
2021
Q2 		$12.3M Buy
286,810
+22,873
+9% +$962K 0.08% 154
2021
Q1 		$10.2M Buy
263,937
+67,303
+34% +$2.55M 0.08% 154
2020
Q4 		$7.07M Buy
196,634
+26,108
+15% +$941K 0.06% 163
2020
Q3 		$6.52M Sell
170,526
-88,045
-34% -$3.39M 0.06% 141
2020
Q2 		$9.08M Buy
+258,571
New +$9.31M 0.1% 117

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank Julius Baer & Co's BSX Position: Q2 2026 in Review

Bank Julius Baer & Co reduced its Boston Scientific (BSX) stake by 90% in Q2 2026, selling an estimated $10.1M and leaving 19,650 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Bank Julius Baer & Co first reported a position in BSX in Q2 2020 and has held it in 25 quarters since. The position peaked at $44.8M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bank Julius Baer & Co held 19,650 shares of Boston Scientific worth $840K as of Q2 2026.
  • Bank Julius Baer & Co sold 185,654 Boston Scientific shares in Q2 2026, an estimated $10.1M.
  • Boston Scientific made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #413 holding.
  • Bank Julius Baer & Co first reported a position in Boston Scientific in Q2 2020 and has held it in 25 quarters since.
  • Bank Julius Baer & Co's Boston Scientific position peaked at $44.8M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.